Powering the Creation of Cell & Gene Therapies
At a speed the world deserves.
3-time Winner
ElevateBio Named to the 2024 CNBC Disruptor 50 List
This is the third time in four years we were recognized as one of the most innovative private companies.
Advancing the Entire Industry
We are a technology-driven genetic medicines company, accelerating access to the cutting-edge technologies, end-to-end manufacturing capabilities and expertise that enable our industry and academic partners to change the future of medicine. Through a connected mission, we are committed to bringing cell and gene therapies to the world.
We Combine Manufacturing, Next-Generation Technologies, and Therapeutic Development, All Under One Roof
We have the manufacturing expertise, technologies, and state-of-the-art facilities at BaseCamp® to manufacture and deliver genetic medicines from concept through commercialization.
Our proprietary technologies – including gene editing, cell therapy enabling technologies, RNA engineering, and viral and non-viral delivery platforms – power the therapies of today and fuel the discoveries of tomorrow.
We are enabling the development of a range of ex vivo and in vivo cell and gene therapies, leveraging our in-house capabilities and expertise to design and develop an array of modalities.
Our Elevated Ecosystem
ElevateBio’s integrated ecosystem of technologies and capabilities enables us to discover, develop, manufacture, and commercialize an unprecedented, broad spectrum of cell and gene therapies and regenerative medicines. Our approach enables a sharp focus on differentiated technologies and R&D efforts, while simultaneously removing barriers to knowledge and new scientific breakthroughs.
End-to-End Capabilities
Technology Platforms
Therapeutic Programs
Press Releases
Publications
// May 23, 2024 | Cell and Gene Therapy
Outsourced Pharma Capacity Update May 2024
Debaditya Bhattacharya, Ph.D. VP, Analytical Development and Miranda Williams Scientist I, Analytical Development discuss BaseCamp’s analytical capabilities and more in a recorded webcast.
// February 28, 2023 | The Long Run
A Life in Biotech & the Cell Therapy Wave: David Hallal on The Long Run
This episode was recorded in person at the JP Morgan Healthcare Conference in San Francisco. Biotech history buffs will especially enjoy the first half, where he talks about what pharmaceutical sales was like and what it was like to work at Amgen in the early days.
// October 12, 2022 | Biotech 2050 Podcast
A New Vision for Cell and Gene Therapy, Andrew Sandford & Michael Paglia, ElevateBio BaseCamp
Andrew Sandford and Michael Paglia are the President and COO, respectively, of ElevateBio BaseCamp, a cell and gene therapy technology company powering transformative therapies. They join us from the company’s manufacturing facilities in Waltham, Massachusetts, for a discussion about the landscape of company creation in the cell and gene therapy space and how ElevateBio is helping companies bring innovation and therapeutics to clinics and patients to help treat and cure diseases.
// July 12, 2022 | Ori Spotlight
Mike Paglia – Chief Operating Officer, ElevateBio
Mike Paglia, COO BaseCamp, on ‘Ori Spotlight’ podcast discussing how Elevate supports the cell and gene therapy industry, the long-term benefits of digital manufacturing processes, and the importance of removing the cost barrier to CGTs.
// March 22, 2022 | Accelerating Clinical Podcast
The Power of Collective Wisdom
Amit Mathur, CIO ElevateBio, on ‘Accelerating Clinical’ podcast, discussing the power of collective wisdom
// February 22, 2022 | Cell & Gene Therapy Insights
Banking on the future of regenerative medicine with cGMP-compliant iPSC lines
Melissa Carpenter, pHD, CSO Regenerative Medicine
// January 18, 2022 | American Builders Quarterly
Mario Miele Begins with the End in Mind
Mario Miele, VP Facilities and Engineering, article discussing the buildout of BaseCamp
Elevated Insights
Partner with ElevateBio®
Wherever you are in your product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies and unmatched manufacturing capabilities.
// Work with us
